"Super testing" conducted early in this year's Arlington Park meet resulted in 26 positives for prednisone but found no evidence of other prohibited substances, according to the Illinois Racing Board.
Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.
More than 700 samples have been reviewed through the National Thoroughbred Racing Association's "super testing" program, with another 1,100 on the way before an Aug. 1 deadline. But in the absence of national equine medication rules, the "calling of positives" will depend upon the jurisdiction.
In a letter to the National Thoroughbred Racing Association, a group of chemists and veterinarians who form the Testing Integrity Program has warned that "super testing," as it is called, could create a public relations nightmare for the racing industry should the betting public believe use of illegal medications is rampant.
Most Popular Stories
- Encouraging Starts to Saratoga, Del Mar Meets
- Commanding Curve Entered in Curlin Stakes
- Better Lucky Shines; My Miss Aurelia Third
- Filly Untapable Works Toward Haskell
- Will Take Charge Works Toward Whitney
- Grade I Winner Heir Kitty Tops Del Mar Sale
- Kiss to Remember Steps Up in Indiana Grand
- Milestone Win 1,000 for Jockey Magrell
- Matz Says He Nearly Retired Somali Lemonade
- Favorite Tale, Choctaw Chuck Top Quick Call